Table 1.
Phenomena | Stage 1 | Stage 2 | Stage 3 |
---|---|---|---|
Proliferation | activated | variable | suppressed |
Dominance 1 of growth factors | yes | no | no |
Insulin resistance | no | possible | yes |
Phosphoinositide 3-kinases (PI3K) 2 |
activation | not typical | not typical |
mTORC1 expression | high | variable | variable or low |
Autophagy | low | elevated | high |
Inflammasomes | low | NLRP3 activation in various cells | |
Apoptosis | possible | possible | possible |
Programmed necrosis 3 | not typical | unlikely | possible |
Effects of SR on PRR | suppressed | variable | activated |
Purinergic receptors 4 | P1 | P2X and P2Y | P2X and P2Y |
p53/NF-κB ratio | ↑/↓ | ↓/↑ | ↓/↑ |
Mitogen activated protein kinases |
ERK > JNK and p38 | ERK < JNK and p38 | ERK < JNK and p38 |
Production and reception of pro-inflammatory cytokines |
moderate | high | Unstable 4 |
iNOS endotheliocytes | inactive | inactive | active |
cNOS endotheliocytes | ? | inhibited | ? |
Unfolded protein response | progression | ||
ROS formation | progression | ||
NF-κB, AP-1, HIF-1α, HSFs, Egr | progression of expression of these transcription factors | ||
The role of non-coding RNA | depends on cell type and formation of extracellular vesicles |
Note: It is the author’s integral table compiled as a result of the analysis of numerous literature data presented in the text of Section 2.5. 1—in the cytokine spectrum; 2—PI3K, which is dependent on insulin and many growth factors; 3—pyroptosis, necroptosis, NETosis, autophagic cell death; 4—main ligands: for P1—adenosine, for P2—ATP; ↑/↓—more/less; SR—scavenger receptor; PRR—pattern recognition receptor; ROS—reactive oxygen species; NOS—NO synthase: i—inducible and c—constitutive.